The Stagnation Genome Diagnostic
Stagnation Slaughters. Strategy Saves. Speed Scales.
The two-minute physical that turns “something feels wrong” into a number, a severity band, and the exact gene to kill first.
Your business isn’t dying quickly. That would force honest recognition. It’s dying slowly, comfortably, surrounded by leaders nodding along to the same recycled platitudes that created the problem — and every operational metric is green while the thing actually killing the company runs untouched below the surface.
I learned this standing in a refrigeration plant losing five hundred thousand dollars a day. One thousand employees. Sixty-hour weeks. Quality scores climbing, complaints falling, every dashboard green. I asked why a routine engineering change needed seventeen signatures and got the seven words that explain most corporate death: “That’s how we’ve always done it.” The effects were obvious to everyone. What nobody could explain was why — why every fix accelerated decline, why working harder produced worse results, why decades of experience had become a liability.
The answer isn’t circumstantial. It’s genetic. Stagnation behaves like a set of genetic predispositions that don’t show up on standard tests until the patient is already in trouble. This diagnostic makes the invisible disease visible — and it does it before the post-mortem, while you still have cash flow, talent, and choices. The fastest way to see it for yourself is to take the free business stagnation test and get your number.
The Stagnation Genome Diagnostic scores your organization across five underlying “genes” and ten observable warning signs, weights each by severity, and returns a single number from 0 to 28 — so the disease driving your decline gets named and ranked instead of hiding behind metrics that all read green.
Score your company in 2 minutes →
- Why Most “How Are We Doing” Reviews Miss the Disease
- The Engine: Five Genes, Ten Signs, One Score
- How the Scoring Works
- Take the Diagnostic
- How to Read Your Score
- The Five Genes, Decoded
- What This Actually Unlocks
Why Most “How Are We Doing” Reviews Miss the Disease
Standard business reviews measure symptoms and optimize metrics while the genetic drivers stay untouched, which guarantees relapse the moment crisis pressure eases. The Stagnation Genome scores the underlying causes instead — so you treat the disease, not the dashboard.
Most leadership teams have forty-seven slides describing their problems and not one that explains the cause. They track revenue, margin, share, satisfaction. All lagging indicators. All symptoms. When the symptoms worsen, they declare war on the symptoms: share dropping, so cut price; margins compressing, so cut costs; talent leaving, so hire cheaper replacements who won’t challenge anything. Every intervention treats a surface manifestation, and every one of them, in a sick organization, makes the disease worse.
The reason is simple and uncomfortable. You can’t fix what you can’t name. A company can run every quality program in the catalog and still die, because it was never a quality problem — it was cognitive blindness, or innovation suppression, or structural calcification quietly metastasizing while the quality scores climbed. Diagnose the wrong disease and you prescribe the wrong cure, and the wrong cure on a stagnating business isn’t neutral. It’s fatal.
The Engine: Five Genes, Ten Signs, One Score
The diagnostic reads stagnation on two layers: five genes that describe the predisposition (performance decline, environmental misalignment, cognitive blindness, structural calcification, innovation suppression) and ten observable warning signs that prove the genes are active. Severity weighting turns the ten signs into one comparable score.
Five genes drive organizational decline. The Performance Decline Gene is the spiral where every fix accelerates the fall. The Environmental Misalignment Gene is being world-class at something the market stopped wanting. The Cognitive Blindness Gene is explaining three years of decline as “temporary market conditions.” The Structural Calcification Gene is the seventeen signatures — bureaucracy that ossifies faster than markets move. The Innovation Suppression Gene is killing every idea that might threaten today’s revenue. Individually they’re dangerous. Combined, they don’t add — they multiply, which is how a company hits full genome expression and enters a death spiral that feels survivable right up until it isn’t.
Genes are invisible, though — you can’t show a board a gene. So the diagnostic measures ten observable warning signs that each correlate to the genes: change allergy, innovation paralysis, the talent spiral, market blindness, the innovation echo chamber, the legacy trap, the expertise paradox, the KPI illusion, bureaucratic bloat, and data delusion. Multiple signs firing together confirm which genes are active and predict the trajectory with uncomfortable accuracy. The fastest way to see your own pattern is to run the diagnostic and get your most-active gene.
How the Scoring Works
Each warning sign carries a severity weight — gateway diseases score highest, friction symptoms score lowest — and your answers sum into a 0–28 score that drops you into one of four severity bands. The weighting means the symptoms that kill you fastest dominate the result.
The two gateway diseases — change allergy and innovation paralysis — are weighted heaviest, because once an organization’s antibodies start killing new ideas systematically, every other symptom gets exponentially harder to cure. The high-severity signs (talent spiral, market blindness, innovation echo chamber, legacy trap) sit in the middle. The friction symptoms (bureaucratic bloat, data delusion) score lowest — real, but rarely fatal on their own.
| Severity tier | Warning signs | Weight |
|---|---|---|
| Critical | Change Allergy, Innovation Paralysis | 5 points each |
| High | Talent Spiral, Market Blindness, Innovation Echo Chamber, Legacy Trap | 3 points each |
| Moderate | Expertise Paradox, KPI Illusion | 2 points each |
| Lower | Bureaucratic Bloat, Data Delusion | 1 point each |
Take the Diagnostic
Ten questions, one per warning sign, about two minutes. There are no wrong answers, only useful ones — and the only way to score it generously is to lie to yourself, which just buys you a wrong prescription.
The diagnostic returns your numerical score, your severity band, and the single most active gene — the one to aim at first. Score honestly: this is the difference between catching the disease at the physical and finding out at the post-mortem.
Take the free Stagnation Genome Diagnostic →
How to Read Your Score
Your 0–28 score maps to four bands — Early Stage, Moderate, Severe, and Critical — each with a different survival probability and a different clock. The higher the score, the shorter the runway and the more radical the required intervention.
| Score | Band | What it means |
|---|---|---|
| 0–5 | Early Stage | Intervention success above 90%. You caught it early — act before the genes activate. |
| 6–10 | Moderate | Turnaround needed within 12 months. ~60% success with aggressive action. |
| 11–20 | Severe | Crisis imminent — act within 90 days. ~30% success even with radical change. |
| 21–28 | Critical | Immediate reinvention. Below 10% success. Multiple genes in full expression. |
Diagnosable means treatable. The refrigeration division scored a 27 — full genome expression, half a million dollars a day in losses — and it survived. If a 27 can be reversed, so can wherever you scored. But every quarter you wait, the score climbs, because stagnation genes don’t pause while you deliberate.
The score is only half the read. The active gene tells you which weapon to reach for first. A high score driven by structural calcification is a decision-velocity problem; the same score driven by innovation suppression is a courage-and-capital problem. Same number, different cure. Haven’t scored yet? Run the business stagnation test first — then come back and read your band. And if you land in Severe or Critical, it’s worth a conversation: book a confidential walkthrough with Todd.
The Five Genes, Decoded
Each gene has a distinct mechanism and a distinct intervention. Knowing which one is most active is what turns a generic “we’re stagnating” into a specific first move.
The Performance Decline Gene is the thrashing spiral — cost cuts that work in healthy companies accelerate death in sick ones. The fix is concentrating intensity on the few activities that actually matter instead of thrashing harder. The Environmental Misalignment Gene is past success becoming a present prison; the fix is breaking the orthodoxies that trap you in capabilities the market abandoned. The Cognitive Blindness Gene is the inability to see what outsiders recognize immediately; the fix is forcing recognition through outside voices and the question every leader avoids: what would you do if you had ninety days to transform this or it dies? The Structural Calcification Gene is bureaucratic sludge; the fix is decision velocity — deciding at 70% confidence instead of waiting for 95% that arrives after the opportunity closes. The Innovation Suppression Gene is protecting yesterday’s revenue at the cost of tomorrow’s; it’s the gateway disease, and the fix is funding the things that cannibalize you before a competitor does it for you.
What This Actually Unlocks
Run once, the diagnostic tells you how sick you are and which gene to treat first. Run with your top ten leaders, it ends the argument about whether there’s even a problem — because everyone’s scoring the same disease at the same time, in numbers, instead of trading opinions in a conference room.
The real power isn’t the score. It’s what the score forces. Most leadership teams already know what’s wrong — they describe the problems fluently and list the solutions accurately. What they lack isn’t knowledge; it’s permission and urgency. A shared number strips both excuses away. You stop debating whether decline is “temporary market conditions” and start naming which gene is active, how severe, and what gets done about it this quarter. That’s the whole game: find out at the physical, not the post-mortem. When you’re ready to turn a score into a plan, bring your results to a working session with Todd.
Run the Stagnation Genome Diagnostic on Your Organization
Eighty percent of businesses are stagnating right now — slowly, comfortably, invisibly. Most find out which gene was killing them at the post-mortem. This is how you find out at the physical. Score yourself, name the gene, and start the war on stagnation before the crisis forces it.
Take the Free Stagnation Test →
Book a Walkthrough with Todd